12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.
Femasys Q1 EPS $(0.24) Up From $(1.84) YoY, Sales $321.40K Down From $329.77K YoY
Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.24) per share. This is a 86.96 percent increase over losses of $(1.84) per share from the same period last year. The company reported $321.40 thousand in sales this
HC Wainwright & Co. Initiates Coverage On Femasys with Buy Rating, Announces Price Target of $8
HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Femasys (NASDAQ:FEMY) with a Buy rating and announces Price Target of $8.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows.
31 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Resonant Inc. (NASDAQ: RESN) jumped 249% to $4.29 after Murata Electronics announced plans to buy the company at $4.50 per share in cash.
78 Biggest Movers From Friday
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.